Abstract:Random screening suggested that the EtOH extract of Artemisia myriantha (Asteraceae) and its EtOAc fraction had cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. Bioassay-guided isolation of the most active fractions (Fr. C and Fr. D) afforded 19 new sesquiterpenolides, artemyrianolides A–S (1–19), involving 13 germacranolides (1–13), four guaianolides (14–17), and two eudesmanolides (18 and 19), together with 16 known sesquiterpenoids (20–35). The new compounds were characterized by physical data analyses (HRESIMS, IR, 1D and 2D NMR, ECD), and the absolute configurations of compounds 1, 2, and 11 were determined by X-ray crystallography. Structurally, compounds 2 and 11–13 maintain an uncommon cis-fused 10/5 bicyclic system and compound 12 possesses an unusual (7S) configuration. Twenty of the compounds exhibited cytotoxicity against HepG2, Huh7, and SMMC-7721 cell lines. Compound 9 showed cytotoxic activity on both HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM, and compounds 8 and 33 showed cytotoxicity to the three human hepatoma cell lines with IC50 values of 4.9 and 7.4 μM (HepG2), 4.3 and 7.8 μM (Huh7), and 3.1 and 9.8 μM (SMMC-7721), respectively.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00396?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00396</a>.Structures of known compounds 20–35; preassayed result of cytotoxicity for the isolates against HepG2 cells; experimental and calculated ECD spectra of compounds 10 and 12–19; HRESIMS, [α]D, IR, UV, 1D and 2D NMR spectra of compounds 1–19 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_001.pdf">PDF</a>)X-ray crystallographic data of compound 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_002.cif">CIF</a>)X-ray crystallographic data of compound 2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_003.cif">CIF</a>)X-ray crystallographic data of compound 11 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00396/suppl_file/np0c00396_si_004.cif">CIF</a>)This article has not yet been cited by other publications.

Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT/STAT signaling pathway

Artematrovirenolides A—D and Artematrolides S—Z, Sesquiterpenoid Dimers with Cytotoxicity against Three Hepatoma Cell Lines from Artemisia atrovirens

Artemeriopolides A‒D, two types of sesquiterpenoid dimers with rare carbon skeletons from Artemisia eriopoda and their antihepatoma cytotoxicity

Artemiprinolides A−M, thirteen undescribed sesquiterpenoid dimers from Artemisia princeps and their antihepatoma activity

Guaiane‐type sesquiterpenoid dimers from Artemisia zhongdianensis and antihepatoma carcinoma activity via the p38MAPK pathway

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Structurally diverse sesquiterpenoids from the aerial parts of Artemisia annua (Qinghao) and their striking systemically anti-inflammatory activities

Liver injury protection of Artemisia stechmanniana besser through PI3K/AKT pathway

Discovery and modulation of diterpenoid metabolism improves glandular trichome formation, artemisinin production and stress resilience in Artemisia annua

Discovery of novel dihydroartemisinin-cinnamic hybrids inducing lung cancer cells apoptosis via inhibition of Akt/Bad signal pathway

Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as Toll-like receptor 4 antagonists

Artemyrianolides A–S, Cytotoxic Sesquiterpenoids from Artemisia myriantha

Modification of a natural diterpene and its antitumor mechanism: Promoting apoptosis, suppressing migration, and inhibiting angiogenesis

Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents

Dihydromyricetin from Ampelopsis grossedentata and its derivatives: Structural characterization and anti-hepatocellular carcinoma activity

New eudesmanolides from Artemisia verlotorum and their potential targets of hepatocellular carcinoma by network pharmacology

Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties

Progress on the Study of Anti-tumor Mechanisms of Dihydroartemisinin

Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers

Sesquiterpenoids and Triterpenoids with Anti-Inflammatory Effects from Artemisia Vulgaris L

Design, Synthesis and Structure-Activity Relationship Studies of Meridianin Derivatives as Novel JAK/STAT3 Signaling Inhibitors